Vidium Animal Health, now part of Anivive Lifesciences, is at the forefront of veterinary oncology, utilizing advanced genomic technologies and specialty pathology services to enhance the diagnosis and treatment of cancer in pets. Their flagship diagnostic test, SearchLight DNA®, is a next-generation genomic diagnostic tool that analyzes 120 cancer-related genes, providing critical insights into canine cancers. This test is designed to aid veterinarians in making informed decisions regarding diagnosis and treatment, thereby facilitating a more personalized approach to veterinary care. Additionally, Vidium offers a comprehensive range of specialty pathology services, focusing on various types of cancer and other pathologies, which further supports veterinary teams in managing complex cases.

The integration of precision medicine into Vidium's research and development efforts signifies a transformative shift in how pet diseases are understood and treated. By combining genomic and molecular diagnostics with traditional pathology, Vidium aims to provide a holistic view of a pet's health, enabling more effective monitoring and treatment strategies. Their collaboration with the Translational Genomics Research Institute (TGen) underscores their commitment to leveraging cutting-edge research in genomics to improve outcomes for pets diagnosed with cancer. This innovative approach not only enhances the understanding of cancer in animals but also aligns with the broader movement towards personalized medicine in veterinary practice.

United States

By informing veterinarians and pet parents about which mutations are causing their pet's cancer to grow and spread, we intend to open up the use of precision medicine to combat canine cancer in new and more effective ways.

Vidium is dedicated to unravelling the genetic components of common and complex diseases, including cancer. As a result, the practice of medicine targeting these conditions can be more rational, more precise and more personal. Our focus is on shifting paradigms in cancer treatment to enable cures for cancer and other serious diseases in pets through programs at the intersection of personalized medicine and comparative genomics.

Vidium Animal Health

Company Details